John Langlands, Ph.D.Vice President Pre-Clinical Research
Joining Naegis in the summer of 2013, Dr. John Langlands brings over 20 years of experience in the development of new pharmaceuticals. John obtained his Ph.D. in pharmacology from the University of Strathclyde and has extensive experience in inflammatory diseases, in particular respiratory and allergic conditions. He has worked with several early stage biopharmaceutical companies with a focus on preclinical regulatory strategies and early clinical development programs required to obtain proof of value for future project development. He has also been involved in strategic planning and translation of discovery concepts to clinical application, and implementation of quality management programs in various regulatory and clinical settings. Using his wide breadth of experience in drug development, John was the Program Authority and Senior Lecturer for postgraduate training in Pharmaceutical Medicine & Drug Development for several years at UNSW in Sydney, Australia and prior to that held senior roles in preclinical and clinical research at Inflazyme Pharmaceuticals.